Concepedia
Statistics
Publications
15
Citations
264
H-Index
12
Active since
2015
Affiliations
National Institutes of Health(Current)
University of Maryland, Baltimore
Center for Cancer Research
National Cancer Institute
National Institutes of Health Clinical Center
Noa G. Holtzman is an author at National Institutes of Health specializing in hematology, medicine, and oncology.
Publications per year
2015–2024
Incidence and outcomes of cytomegalovirus reactivation after chimeric antigen receptor T-cell therapy
Rick Y. Lin, Anthony D. Anderson, Yoichiro Natori et al. · Blood Advances · 2024 · 36 citations · Full text
Life Sciences, Immunology, Infectious Diseases +17
The impact of bridging therapy prior to CD19‐directed chimeric antigen receptor T‐cell therapy in patients with large B‐cell lymphoma
Forat Lutfi, Noa G. Holtzman, Ankit Kansagra et al. · British Journal of Haematology · 2021 · 27 citations · Full text
Medicine, Hematology, Oncology +15
Chimeric antigen receptor T‐cell therapy after allogeneic stem cell transplant for relapsed/refractory large B‐cell lymphoma
Forat Lutfi, Noa G. Holtzman, Jonathan Siglin et al. · British Journal of Haematology · 2020 · 24 citations · Full text
Reverse Pseudohyperkalemia: An Important Clinical Entity in Chronic Lymphocytic Leukemia
Sahar Rostami-Mansoor, Noa G. Holtzman, Ashkan Emadi · Case Reports in Hematology · 2015 · 21 citations · Full text
A randomized phase 2 trial of pomalidomide in subjects failing prior therapy for chronic graft-versus-host disease
Lauren M. Curtis, Alen Ostojić, David Venzon et al. · Blood · 2020 · 21 citations · Full text
Life Sciences, Clinical Sciences, Pharmacotherapy +6
1–5 of 15